Country Trust Bank Has Raised Biogen Common (BIIB) Holding By $1.05 Million; PrivateBancorp (PVTB) Had 3 Bulls

November 15, 2017 - By Peter Erickson

Among 12 analysts covering Privatebancorp Inc. (NASDAQ:PVTB), 3 have Buy rating, 0 Sell and 9 Hold. Therefore 25% are positive. Privatebancorp Inc. had 20 analyst reports since July 20, 2015 according to SRatingsIntel. On Friday, June 2 the stock rating was maintained by Jefferies with “Hold”. The firm earned “Buy” rating on Tuesday, February 9 by Suntrust Robinson. The stock of PrivateBancorp Inc (NASDAQ:PVTB) has “Outperform” rating given on Wednesday, January 13 by RBC Capital Markets. FIG Partners upgraded the shares of PVTB in report on Thursday, February 4 to “Outperform” rating. Zacks downgraded PrivateBancorp Inc (NASDAQ:PVTB) on Wednesday, August 19 to “Buy” rating. Keefe Bruyette & Woods downgraded it to “Hold” rating and $6300 target in Friday, May 26 report. Zacks downgraded PrivateBancorp Inc (NASDAQ:PVTB) on Tuesday, August 25 to “Buy” rating. The rating was initiated by Stephens with “Equal Weight” on Friday, October 9. Zacks downgraded the stock to “Hold” rating in Friday, September 4 report. As per Thursday, June 30, the company rating was downgraded by Keefe Bruyette & Woods. See PrivateBancorp Inc (NASDAQ:PVTB) latest ratings:

02/06/2017 Broker: Jefferies Rating: Hold New Target: $44.0000 Maintain
26/05/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $63.0000 Downgrade

Country Trust Bank increased Biogen Inc. Common (BIIB) stake by 4.3% reported in 2017Q2 SEC filing. Country Trust Bank acquired 3,858 shares as Biogen Inc. Common (BIIB)’s stock declined 13.45%. The Country Trust Bank holds 93,676 shares with $25.42M value, up from 89,818 last quarter. Biogen Inc. Common now has $65.49B valuation. It is 0.00% or $0 reaching $309.69 per share. It is down 4.94% since November 15, 2016 and is uptrending. It has underperformed by 11.76% the S&P500.

Investors sentiment decreased to 0.88 in Q2 2017. Its down 0.16, from 1.04 in 2017Q1. It dropped, as 81 investors sold BIIB shares while 321 reduced holdings. 78 funds opened positions while 277 raised stakes. 180.66 million shares or 1.01% less from 182.50 million shares in 2017Q1 were reported. New Mexico Educational Retirement Board has 0.28% invested in Biogen Inc (NASDAQ:BIIB) for 19,874 shares. Alps Advsrs Inc has 2,109 shares for 0% of their portfolio. Tributary Management Ltd Llc holds 0.04% of its portfolio in Biogen Inc (NASDAQ:BIIB) for 1,650 shares. 1,301 were accumulated by Roundview Capital Ltd Liability Company. Lowe Brockenbrough Co owns 1,021 shares. Cambiar Investors Ltd Limited Liability Company invested in 240,228 shares or 1.02% of the stock. Appleton Prtnrs Ma accumulated 0.26% or 5,724 shares. Norinchukin Commercial Bank The holds 0.14% or 25,814 shares in its portfolio. Oakworth Capital Incorporated holds 0% of its portfolio in Biogen Inc (NASDAQ:BIIB) for 9 shares. Grantham Mayo Van Otterloo & Limited Liability Corporation has invested 0.04% in Biogen Inc (NASDAQ:BIIB). Commercial Bank Of Nova Scotia invested 0.07% of its portfolio in Biogen Inc (NASDAQ:BIIB). Nuveen Asset Mngmt Limited Liability Com stated it has 103,393 shares or 0.18% of all its holdings. Atlantic Trust Grp Ltd Co holds 15,848 shares. Cap One National Association reported 0.46% stake. 444,727 are held by Apg Asset Mngmt Nv.

Since June 9, 2017, it had 0 insider purchases, and 1 sale for $277,840 activity. 1,084 shares were sold by Posner Brian S, worth $277,840.

Country Trust Bank decreased Gentex Corporation Common (NASDAQ:GNTX) stake by 93,030 shares to 1.35 million valued at $25.58 million in 2017Q2. It also reduced Cef Healthcare Sector Spdr Etf (XLV) stake by 46,183 shares and now owns 2,480 shares. Wal (NYSE:WMT) was reduced too.

Among 30 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 20 have Buy rating, 0 Sell and 10 Hold. Therefore 67% are positive. Biogen Idec Inc. had 89 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, June 14 by Morgan Stanley. The firm has “Outperform” rating by BMO Capital Markets given on Wednesday, October 25. Raymond James maintained the stock with “Strong Buy” rating in Thursday, December 29 report. The company was maintained on Wednesday, October 4 by RBC Capital Markets. On Wednesday, October 25 the stock rating was maintained by UBS with “Neutral”. Cantor Fitzgerald maintained the stock with “Hold” rating in Tuesday, October 24 report. The firm earned “Hold” rating on Friday, October 20 by BMO Capital Markets. The rating was reinitiated by Jefferies on Tuesday, July 11 with “Hold”. The stock has “Buy” rating by Citigroup on Tuesday, February 7. The rating was maintained by Robert W. Baird with “Neutral” on Friday, March 11.

Investors sentiment decreased to 0 in Q2 2017. Its down 1.31, from 1.31 in 2017Q1. It turned negative, as 206 investors sold PrivateBancorp Inc shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 1.48 million shares or 97.68% less from 63.53 million shares in 2017Q1 were reported. Glenmede Trust Na has 0% invested in PrivateBancorp Inc (NASDAQ:PVTB). Ancora Advisors Limited Co accumulated 70,000 shares. Alpine Associate Mgmt has invested 2.33% in PrivateBancorp Inc (NASDAQ:PVTB).

It closed at $60.97 lastly. It is down 46.55% since November 15, 2016 and is uptrending. It has outperformed by 29.85% the S&P500.

Since June 8, 2017, it had 0 buys, and 9 sales for $54.33 million activity. The insider Van Solkema Kevin sold $6.98M. 100,337 shares valued at $6.05 million were sold by Killips Kevin M on Monday, June 12. 16,316 shares were sold by Carey Paul E, worth $975,436. 29,383 shares were sold by BOBINS NORMAN, worth $1.78M. Evans Jennifer sold $4.25M worth of PrivateBancorp Inc (NASDAQ:PVTB) on Friday, June 16. $4.70 million worth of PrivateBancorp Inc (NASDAQ:PVTB) shares were sold by Case Karen B.. The insider Richman Larry D. sold 312,679 shares worth $18.68 million.

PrivateBancorp, Inc. is a bank holding firm for The PrivateBank and Trust Company . The company has market cap of $4.86 billion. Through the Bank, the Company provides customized business and personal financial services to middle market companies, as well as business owners, executives, entrepreneurs and families in the markets and communities it serves. It has a 22.98 P/E ratio. The Firm operates through three operating divisions: Banking, Asset Management and Holding Company activities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :